Lewina O Lee1, Carol A Prescott. 1. aDepartment of Epidemiology, Boston University School of Public Health bNational Center for Posttraumatic Stress Disorder, Veterans Affairs Boston Healthcare System, Boston, Massachusetts cDepartment of Psychology and Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
Abstract
OBJECTIVES: The aims of this study were (i) to examine genotypic association of the catechol-O-methyltransferase (COMT) val158met polymorphism with anxiety-related traits with a meta-analysis; (ii) to examine sex and ethnicity as moderators of the association; and (iii) to evaluate whether the association differed by particular anxiety traits. METHODS: Association studies of the COMT val158met polymorphism and anxiety traits were identified from the PubMed or PsycInfo databases, conference abstracts, and listserv postings. Exclusion criteria were (a) pediatric samples, (b) exclusively clinical samples, and (c) samples selected for a nonanxiety phenotype. Standardized mean differences in anxiety between genotypes were aggregated to produce mean effect sizes across all available samples, and for subgroups stratified by sex and ethnicity (Whites vs. Asians). Construct-specific analysis was conducted to evaluate the association of COMT with neuroticism, harm avoidance, and behavioral inhibition. RESULTS: Twenty-seven eligible studies (N=15 979) with available data were identified. Overall findings indicate sex-specific and ethnic-specific effects: valine homozygotes had higher neuroticism than methionine homozygotes in studies of White males [mean effect size(Equation is included in full-text article.)=0.13; 95% CI 0.02, 0.25; P=0.03], and higher harm avoidance in studies of Asian males ((Equation is included in full-text article.)=0.43; 95% CI 0.14, 0.72; P=0.004). No significant associations were found in women and effect sizes were diminished when studies were aggregated across ethnicity or anxiety traits. CONCLUSION: This meta-analysis provides evidence for sex and ethnic differences in the association of the COMT val158met polymorphism with anxiety traits. Our findings contribute to current knowledge on the relation between prefrontal dopaminergic transmission and anxiety.
OBJECTIVES: The aims of this study were (i) to examine genotypic association of the catechol-O-methyltransferase (COMT) val158met polymorphism with anxiety-related traits with a meta-analysis; (ii) to examine sex and ethnicity as moderators of the association; and (iii) to evaluate whether the association differed by particular anxiety traits. METHODS: Association studies of the COMTval158met polymorphism and anxiety traits were identified from the PubMed or PsycInfo databases, conference abstracts, and listserv postings. Exclusion criteria were (a) pediatric samples, (b) exclusively clinical samples, and (c) samples selected for a nonanxiety phenotype. Standardized mean differences in anxiety between genotypes were aggregated to produce mean effect sizes across all available samples, and for subgroups stratified by sex and ethnicity (Whites vs. Asians). Construct-specific analysis was conducted to evaluate the association of COMT with neuroticism, harm avoidance, and behavioral inhibition. RESULTS: Twenty-seven eligible studies (N=15 979) with available data were identified. Overall findings indicate sex-specific and ethnic-specific effects: valine homozygotes had higher neuroticism than methionine homozygotes in studies of White males [mean effect size(Equation is included in full-text article.)=0.13; 95% CI 0.02, 0.25; P=0.03], and higher harm avoidance in studies of Asian males ((Equation is included in full-text article.)=0.43; 95% CI 0.14, 0.72; P=0.004). No significant associations were found in women and effect sizes were diminished when studies were aggregated across ethnicity or anxiety traits. CONCLUSION: This meta-analysis provides evidence for sex and ethnic differences in the association of the COMTval158met polymorphism with anxiety traits. Our findings contribute to current knowledge on the relation between prefrontal dopaminergic transmission and anxiety.
Authors: Giuseppe Blasi; Venkata S Mattay; Alessandro Bertolino; Brita Elvevåg; Joseph H Callicott; Saumitra Das; Bhaskar S Kolachana; Michael F Egan; Terry E Goldberg; Daniel R Weinberger Journal: J Neurosci Date: 2005-05-18 Impact factor: 6.167
Authors: Juliana Yacubian; Tobias Sommer; Katrin Schroeder; Jan Gläscher; Raffael Kalisch; Boris Leuenberger; Dieter F Braus; Christian Büchel Journal: Proc Natl Acad Sci U S A Date: 2007-05-02 Impact factor: 11.205
Authors: Francesca Ducci; Mary-Anne Enoch; Samuel Funt; Matti Virkkunen; Bernard Albaugh; David Goldman Journal: Alcohol Date: 2007-02 Impact factor: 2.405
Authors: Sarah E Harris; Alan F Wright; Caroline Hayward; John M Starr; Lawrence J Whalley; Ian J Deary Journal: Neurosci Lett Date: 2005-09-02 Impact factor: 3.046
Authors: Susan A Korrick; Juliette C Madan; Hannah E Laue; Margaret R Karagas; Modupe O Coker; David C Bellinger; Emily R Baker Journal: Pediatr Res Date: 2021-11-04 Impact factor: 3.953
Authors: N S Corral-Frías; D A Pizzagalli; J M Carré; L J Michalski; Y S Nikolova; R H Perlis; J Fagerness; M R Lee; E Drabant Conley; T M Lancaster; S Haddad; A Wolf; J W Smoller; A R Hariri; R Bogdan Journal: Genes Brain Behav Date: 2016-06 Impact factor: 3.449
Authors: Chris Barkus; Clio Korn; Katharina Stumpenhorst; Linda M Laatikainen; Dominic Ballard; Sheena Lee; Trevor Sharp; Paul J Harrison; David M Bannerman; Daniel R Weinberger; Jingshan Chen; Elizabeth M Tunbridge Journal: Neuropsychopharmacology Date: 2016-07-08 Impact factor: 7.853
Authors: Michelle N Servaas; Linda Geerligs; Jojanneke A Bastiaansen; Remco J Renken; Jan-Bernard C Marsman; Ilja M Nolte; Johan Ormel; André Aleman; Harriëtte Riese Journal: Brain Imaging Behav Date: 2017-12 Impact factor: 3.978